At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 798 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
In Brief
A Phase 4 clinical trial evaluating Dexmedetomidine and Placebo for Heart Disease. Completed, enrolled 798 participants across 1 site.
Detailed Summary
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Disease
CountriesUnited States
CollaboratorsHospira, now a wholly owned subsidiary of Pfizer
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJun 2013
First PostedDec 2013
Primary CompletionDec 2018
Study CompletionDec 2020
TodayJul 2026
First PostedDec 9, 2013
Enrollment StartJun 1, 2013
Primary CompletionDec 1, 2018
Study CompletionDec 18, 2020
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 12.6 years ago
Interventions
Dexmedetomidinedrug
Dexmedetomidine
Placebodrug
Normal saline administration matching dexmedetomidine rate of infusion